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Gene 21 is one of at least four genes transcribed during latent infection of varicella-zoster virus (VZV) in human ganglia.
It may encode a nucleocapsid protein, but its function in lytic and latent infection is not clear. To characterize further the
structure and the function of the gene 21 open reading frame (ORF 21), precise localization of its transcripts and their termini
was determined by using Northern analysis, S1 nuclease or RNase protection, and primer extension assays. One abundant
3.5-kb transcript that spans ORF 21 was identified. A predominant transcription start site was defined at 278 nucleotide (nt)
relative to the ORF 21 translation start codon ATG, and two potential TATA elements were identified at 26 and 83 nt upstream
of the 59 end of gene 21 transcripts. Transcription was found to terminate 210 nt beyond the ORF 21 translation stop codon
and immediately before the start codon of ORF 22. In transient expression assays, the ORF 21 showed no significant
transregulatory activity on promoters of diverse kinetic classes. The ORF 21 promoter, however, was transactivated strongly
by VZV infection or by ORF 62.
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GINTRODUCTION
Varicella-zoster virus (VZV) is a neurotropic alphaher-
esvirus that causes both chickenpox (varicella) and
hingles (zoster) (Straus et al., 1988). Varicella results
rom primary infection with the virus, and zoster occurs
pon reactivation of latent VZV infection. The main sites
f latency are the dorsal root and cranial nerve ganglia
Croen et al., 1988). Zoster affects .300,000 Americans
nnually. It typically arises several decades after vari-
ella, but in immunocompromised individuals, zoster of-
en develops sooner and with greater severity or chro-
icity. An understanding of the mechanism underlying
ZV latency might provide new strategies to control re-
urrence of the infection.
The complete 125-kb DNA sequence of VZV genome
as been determined and is predicted to encode 69
pen reading frames (ORF) (Davison et al., 1986). At least
our of the genes are known to be transcribed in latently
nfected human ganglia (Meier et al., 1993, Cohrs et al.,
994–1996): genes 62 and 63 encode immediate early
IE) proteins that are involved in viral gene regulation
Felser et al., 1988; Jackers et al., 1992); gene 29 (Kinch-
ngton et al., 1988) encodes a single-stranded DNA bind-
ng protein; far less is known about the fourth latency
ene product, ORF 21 (Cohrs et al., 1998; Mahalingam et
l., 1998).
1 To whom reprint requests should be addressed at LCI, NIAID, NIH,
ldg. 10, Rm. 11N228, 10 Center Dr., Bethesda, MD 20892-1888. Fax:u301) 496-7383. E-mail: dxia@atlas.niaid.nih.gov.
042-6822/99 304The VZV sequence predicts that ORF 21 is ;3.1 kb
ong. Previous studies indicated that during productive
iral infection, mRNAs of 3.6, 3.1, 3.0, and 2.4 kb in size
re detected that correspond to gene 21 (Gilligan 1994;
ohrs et al., 1998). In latently infected human ganglia,
ene-21-specific sequences were identified by PCR am-
lification and confirmed by cloning the 39 terminus of
ene 21 from a human trigeminal ganglion cDNA library
nriched for VZV transcripts (Cohrs et al., 1994–1996).
VZV gene 21 is thought to encode a 115-kDa nucleo-
apsid protein (Mahalingam et al., 1998), the function of
hich is not known. Its predicted amino acid sequence
hows 47% homology with HSV-1 UL 37. The HSV-1 UL 37
ncodes a late, 120-kDa tegument-associated phospho-
rotein that interacts with HSV-1 ICP8 (the HSV-1 ho-
olog of VZV gene 29) to form a complex that binds
ingle-stranded DNA (Albright and Jenkins, 1993; Shelton
t al., 1994). Neither ICP8 nor UL 37 is expressed during
SV-1 latency.
Here we report on the detailed mapping of gene 21
ranscripts using diverse methods to assay RNA. The
esponsiveness of the ORF 21 promoter to viral transac-
ivators and the potential regulatory effects of ORF 21 on
ther genes using transient transfection assays also are
escribed.
RESULTS
ene 21 encodes a dominant 3.5-kb transcript
Preliminary mapping of the gene 21 transcripts was
ndertaken with Northern hybridization analyses (Fig. 1).
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305TRANSCRIPTION MAPPING OF VZV GENE 21revious studies identified RNAs of 2.4, 3.0, 3.1, and 3.6
b homologous to ORF 21 (Gilligan 1994; Cohrs et al.,
998). To identity ORF 21 transcripts, we prepared North-
rn blots of total RNA or poly(A)1 mRNA from VZV-
nfected MeWo cells and hybridized them with two sin-
le-stranded, antisense riboprobes (probes 8 and 9) and
even more single-stranded, antisense oligonucleotide
robes (probes 1–7; Table 1 and Fig. 1) spanning gene 21
nd the adjacent sequences.
The ORF-21-spanning riboprobe 9 hybridized to an
bundant mRNA of ;3.5-kb in size, a relatively less
bundant 1.5-kb RNA, and a weaker diffuse signal was
etected, migrating at ;9.0–9.5 kb (Fig. 1). The ORF-21-
pecific riboprobe 8 detected a dominant 3.5-kb RNA
pecies and the weaker diffuse 9.0- to 9.5-kb signal. The
FIG. 1. (A) Diagrammatic representation of VZV ORF 21 and the a
ligonucleotide probes/primers are represented by short bars at their a
re represented as arrowheaded bars. The 3.5-kb ORF 21 RNA frag
olyadenylated tails. (B) Northern blot analysis. Total RNA (T) and mR
adiolabeled oligonucleotide probes (1–7) or riboprobes (8 and 9). RNA s
Boehringer Mannheim) and a 2.4–9.5 RNA kb ladder (Gibco-BRL Life.5-kb RNA also was detected by internal ORF-21-spe- tific oligonucleotide probes 3 and 4; probe 5, which
pans the predicted ORF 21 translation stop codon; and
robe 6, which represents the sequence between ORF
1 and ORF 22. No clear 3.5-kb signal was generated by
ybridizations with probe 1 upstream of both ORFs 20
nd 21 or with probe 2, the sequence of which extends
rom 77 to 98 nucleotides (nt) upstream of ORF 21, or with
robe 7, which is homologous to sequences within ORF
2. Weaker reactions for bands of 1.5 to 2.0 kb in size
ere identified by probes 5–7, while the diffuse 9.0- to
.5-kb signal also was recognized by probes 6 and 7 and
robably by probe 5 as well. An additional, ;5.0 kb RNA
pecies was detected by probe 7. No transcripts were
etected in mock-infected MeWo cells.
Based on these hybridization results, we concluded
t ORFs and the probes or primers employed to map its transcripts.
ate positions. RNA/DNA fragments for subcloning or probe generation
etected in (B) is shown with an AAAA stretch representing the 39
) from infected (V) and mock-infected (M) cells were hybridized with
ere estimated from the mobility of a 0.3- to 7.4-kb RNA molecular ladder
logies).djacen
pproxim
ment d
NA (m
izes what the 3.5-kb transcript is the predominant ORF 21
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306 XIA AND STRAUSroduct. It originates from or somewhere downstream of
ase 277 relative to the ORF 21 ATG and terminates
omewhere within the ORFs 21 and 22 intergenic region
r within ORF 22 itself. We further postulate that the 9.0-
o 9.5-kb transcript is the product of ORF 22, initiated
rom within ORF 21 or within the intergenic region, in
ccord with the predicted size of an 8.3-kb coding se-
uence. The 5.0-kb transcript might represent another
ranscript species arising within, or including, ORF 22,
hereas the 1.5- to 2.0-kb transcripts might have initiated
rom within ORF 21 and extending across the intergenic
egion.
ene 21 transcription starts 78 bases upstream of
he ATG
The 59 end of the predominant 3.5-kb gene 21 RNA
as localized using S1 nuclease protection and primer
xtension assays. Probe 10, a DNA fragment comple-
entary to the mRNA, was uniquely labeled at the 59 end
f a BstEII cleavage site (nt. 30847). It was truncated
urther with AseI to generate a fragment ;818 bp in size
panning from 89 bp within the ORF 21 ATG to the
losest AseI site in the plasmid vector. The end-labeled
robe was hybridized to RNA and subjected to S1 diges-
ion and gel resolution. With VZV-infected cell RNA, an
170-bp protected fragment was observed (Fig. 2A).
his size implied that gene 21 transcription initiated at
80 bp upstream of the ATG. No protection product was
een when this probe was hybridized with uninfected
eWo cell RNA and digested with S1 nuclease.
To determine the precise transcription initiation site,
rimer extension analysis was performed using ORF-21-
pecific primer 3, which anneals at bases 54–32 (nt.
0812–30790), and primer 4, which anneals at bases
9–76 (nt. 30857–30834), both downstream relative to the
redicted ORF 21 translation start codon ATG. As shown
n Fig. 2B, both primers revealed one dominant VZV-
pecific extension product at the same position, the A
esidue of nt 30681, which is 78 bp upstream of the ATG.
T
Oligonucleotide Probes/P
Number ORF Sequence (5
1 20/21 TGTGAATTTAACCC
2 20/21 GTAACATCAATAAA
3 21 GTTACTTAAATCAT
4 21 CTCTGGTGACCATG
5 21 CTGTTTTATATTAAG
6 21/22 AGCGTTGAATAAGC
7 22 AGACAAAACGCAG
* NB, Northern blot; PE, primer extension.his position is consistent with the results of the North- trn blot hybridization (Fig. 1) and S1 protection (Fig. 2A)
nd the fact that most RNA polymerase II transcripts
nitiate at a purine nucleotide. The genomic sequences
eighboring this start site are shown in Fig 2C. Two
utative TATA boxes were identified, one is at 26 nt and
he other at 83 nt upstream of the gene 21 transcriptional
tart site. At 179 and 184 bp upstream from the transcrip-
ion initiation site are two consensus CAAT sequences.
hese analyses suggest that the ORF 21 promoter spans
uch or the entire region between genes 20 and 21.
he major gene 21 transcript terminates ;210 nt
ownstream of the ORF 21 stop codon
The Northern blot data suggested that multiple tran-
cripts are homologous to sequences neighboring the 39
nd of the ORF 21. To further define the 39 boundary of
he dominant ORF 21 transcripts, S1 nuclease and
Nase protection assays were employed. Both assays
sed riboprobe 11, which is a 410-nt radiolabeled frag-
ent including 26 nt upstream of ORF 21 stop codon, 355
t beyond the stop codon, and 29 nt of the vector se-
uence. The probe was hybridized with total VZV-in-
ected cell RNA and then digested with S1 nuclease or
n RNase cocktail (A1T1) with different RNA:enzyme
atios and resolved on denaturing gels.
Both assays yielded similar results: namely, that there
ere two protected bands, of ;240 and 380 base in size,
s shown in Figs. 3A and 3B. Bands of 71–78 bases were
ot observed, as reported by Cohrs et al. The 240 bp
uggests that ORF 21 transcription may terminate at
210 nt beyond the stop codon. At this site, there is an
ATAAA consensus sequence situated immediately up-
tream of the predicted ORF 22 start codon (Fig. 3C).
here is no distinct GT-rich element downstream of the
9 end of this ORF 21 transcript RNA. Nonetheless, this
esult is consistent with the Northern blot hybridization
Fig. 1) and the 59 terminus mapping assays (Fig. 2),
hich identified one dominant ORF 21 RNA of ;3.5 kb in
ize, extending from 278 nt of the untranslated region,
Used to Map VZV RNAs
onucleotide
Application*) Location
CT 30496-30476 NB
ATG 30682-30661 NB
AGTT 30812-30790 NB, PE
TTCGTT 30857-30834 NB, PE
ACTC 33885-33862 NB
GTAG 34012-33991 NB
ACT 34403-34383 NBABLE 1
rimers
Olig
9 3 39
CTCAG
AACGC
CCAAA
GTCT
GGTC
ACGT
CACGThrough 3114 nt of the ORF, and ending at $210 nucleo-
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307TRANSCRIPTION MAPPING OF VZV GENE 21ides into the untranslated region and then having a
oly(A) tail.
FIG. 2. Mapping of the transcription initiation site for VZV gene 21 RNA
r VZV-infected cells (V) or with 10 mg of yeast RNA (P) were digested with
s estimated from denatured, end-labeled DNA ladders in lane S. The siz
enerated from VZV-infected cell RNA is shown along side a DNA sequenc
o the transcription initiation site is expanded, and the base at which transc
ranscription initiation site of gene 21. The start codon of translation is indic
ssays are underlined. The numbers above the sequence are nucleotide
hown in italics. The 59 end of the primer extension products and the prote
ranscriptional start site is indicated by: .... The putative TATA boxes aThe larger 380-bp fragment also protected in these two assays extends to the 39 end of the VZV gene
equence of the probe. Obviously, the real 39 end of this
natured DNA probe 10 hybridized with RNA from mock-infected cells (M)
out 50 U of S1 nuclease. The 170-nt size of the protected fragment (arrow)
e probe is indicated by the black dot. (B) The primer extension product
r obtained by using the same primer. The DNA sequence corresponding
initiates is indicated by an arrow. (C) VZV DNA sequence surrounding the
M3. The probes and primers used for Northern blot or primer extension
s in the VZV genome. The BstEII cleavage site used in the study is also
gment in the S1 nuclease protection assay are located by black dots. The
AT boxes are thickly and doubly underlined, respectively.. (A) De
or with
e of th
e ladde
ription
ated by
position
cted fraranscript must be further downstream. This fragment
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308 XIA AND STRAUSay be related to the 1.5- to 2.0-kb or to the 9.0- to 9.5-kb
ranscripts observed in the Northern hybridization anal-
ses (Fig. 1B) because these transcripts can be detected
FIG. 3. Mapping of the transcription termination sites for VZV ORF
omplexes were separated on a 6% denaturing polyacrylamide gel.
ZV-infected cell RNA (5–0.31 mg) were digested with 50 U of S1 nucle
ybridization amount) control is shown in the right-most lane. (B) Prot
Nase digestion. Five micrograms RNA was recovered from mock-infe
ith increasing amounts of RNase A/T1 cocktail (Ambion). In both (A)
rrows as estimated from the positions of molecular size markers (S) a
he transcriptional termination site downstream of ORF 21. The translati
nd 380 base) in the S1 nuclease or RNase protection assay were identi
ATAAA of the transcription termination site is doubly underlined.y the probes spanning sequences nt 33056 (probe 8) to s4403 (probe 7). It does not appear that the 380-bp
ragment is homologous to the 5.0-kb RNA product be-
ause it was not recognized by probe 5, which spans the
. (A) Radiolabeled S1 nuclease–protected fragments from RNA–RNA
icrograms of mock-infected cell RNA and decreasing amounts of
er hybridiztion with riboprobe 11. The 410 base riboprobe 11 (1/16 the
adiolabeled RNA bands are resolved on 8% polyacrylamide gel after
lls or VZV-infected cells, and the hybridized complexes were digested
), the approximate sizes of the protected fragments are indicated by
probes are indicated by black dots. (C) DNA sequences surrounding
p codon of translation is indicated (***). Two protected fragments (240
ween AvaI site and black triangles. The putative polyadenylation signal21 RNA
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309TRANSCRIPTION MAPPING OF VZV GENE 21ntire gene 21 including riboprobe 11 used in the pro-
ection assay.
he gene 21 promoter is responsive to VZV
ransregulatory proteins
Multiple plasmid constructs were used to assess the
esponsiveness of the putative gene 21 promoter to VZV
ransactivators. Plasmids with the promoter regions of
ZV genes 4, 21, and 29 inserted upstream of the CAT
eporter gene (constructs p4CAT, p21CAT, and p29CAT,
espectively) were transfected into Vero cells, and 24 h
ater were superinfected with VZV. All three promoter
onstructs were responsive to VZV infection, with activa-
ion of CAT expression from p4CAT, p21CAT, and p29CAT
f 62-, 32-, and 37-fold, respectively.
In further studies, p21CAT was cotransfected with
lasmids in which VZV genes 4, 10, 21, 61, 62, or combi-
ations of these were driven by the potent CMV imme-
iate-early promoter (Table 2). Among these constructs,
nly VZV gene 62 significantly activated the promoter of
RF 21. Little activation was seen with gene 4 alone, but
otransfection with both genes 4 and 62 led to the higher
evels of activation of the gene 21 promoter.
TABLE 2
Responsiveness of the ORF 21 Promoter to VZV Transactivators*
Effector constructs
Mean counts
(cpm)
Fold-activation
of p21CAT
CMV 1 pCMV 457 1.0
CMV4 1 pCMV 447 1.0 6 0.0
CMV4 1 pCMV62 18930 41.4 6 7.6
CMV 1 pcDNA3 417 1.0
CMV4 1 pcDNA3 583 1.4 6 0.0
CMV21 1 pCMV 358 0.9 6 0.0
CMV62 1 pcDNA3 12183 29.2 6 4.9
CMV4 1 pCMV21 1020 2.5 6 0.5
CMV21 1 pCMV62 12167 29.2 6 4.3
* Mean counts, fold activation, and standard deviation were calcu-
ated from the results of three independent transfection assays.
T
Transregulatory Effects of O
Target
reporter
construct
Putative kinetic
class of the
target gene
No. o
p4 CAT IE
p61CAT IE
p62CAT IE
p29CAT Early
p1TKCAT Early
p21CAT Late?
* The fold-activation was calculated relative to the control experimen
or pCMV62) plasmids was contransfected with the target constructs. The vaGene 21 by itself showed no substantial autoregula-
ory effects. To examine the potential transregulatory
ffects ORF 21 on other genes, the construct pCMV21, in
hich ORF 21 is driven by a CMV promoter, was cotrans-
ected with other VZV promoter–CAT constructs repre-
enting putative immediate-early (p4CAT, p61CAT, or
62CAT), early (p29CAT, p1TKCAT), or the presumably
ate (p21CAT) kinetic classes. In transient expression
ssays (Table 3), ORF 21 did not reproducibly activate or
epress any of the genes tested. For p1TKCAT, there is
ean 2.7-fold increase, but the increase was not repro-
ucible nor statistically significant. As a control, gene 62
ctivated, to some extent, all of the target CAT constructs
ther than one expressing itself. Gene 62 downregulated
ts own promoter, consistent with prior reports (Disney et
l., 1990). These cumulative data indicate that gene 21
as no demonstrable transregulatory activity in the con-
ext of lytic VZV infection.
DISCUSSION
Using a variety of techniques, we defined the primary
ranscript of VZV gene 21 in lytic infection, its promoter
egion, and responsiveness to other VZV transregulatory
roteins. The primary transcript is a ;3.5-kb mRNA that
nitiates at genome position 30681, which is at 26 and 83
p downstream of two canonical TATA elements. Situ-
ted 78 bp downstream of the 59 RNA terminus is the
ranslation start codon ATG. ORF21 extends 3114 bases
o terminate at position 33872. Untranslated RNA ex-
ends 210 bases beyond this region to the 39 terminus
nd poly(A)1 sequence. Additional smaller and larger
ranscripts extending into gene 22 were identified but not
apped definitively.
These data are generally consistent with, but refine,
he earlier analyses of gene 21 transcription by Gilligan
nd Cohrs et al. Gilligan described mRNAs of 2.4, 3.0,
nd 3.6 kb in length of which only the 3.6 kb was felt to
pan the entire gene (Gilligan 1994). This is, undoubtedly,
he product we estimate to be 3.5 kb in length. Cohrs et
l. reported a dominant 3.1-kb transcript homologous to
on Diverse VZV Promoters
endent
s
Fold-activation* by
pCMV21 pCMV62
0.9 6 0.4 7.7 6 2.5
1.3 6 0.7 7.5 6 3.0
0.9 6 0.6 0.4 6 0.3
1.5 6 1.0 10.9 6 6.6
2.7 6 2.7 2.1 6 1.4
1.1 6 0.1 4.9 6 2.1
ich either empty pcDNA (the control for pCMV21) or pCMV (the controlABLE 3
RF 21
f indep
assay
3
3
4
5
8
7
t in wh
lue was set as 1.0 in the control experiments.
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310 XIA AND STRAUSene 21 that initiated at the identical position we deter-
ined for our 3.5-kb RNA (Cohrs et al., 1998).
There are differences, however, in where we each
ocalized the RNA 39 terminus of gene 21. Previously, a 39
erminus was described 45–52 bases beyond a putative
top codon, where an ATTAAA element is situated and
ollowed by T-rich and GT-rich poly(A)1 signal se-
uences seen in other VZV genes (Gilligan 1994). We
bserved a transcriptional terminus at 210 bases after
he stop codon, where there is an AATAAA, a cis-acting
lement used more frequently than ATTAAA in higher
ukaryotic genomes for efficient 39 processing (Gilligan
994). There are no GT-rich sequences in this region,
owever. The reasons for the differences between the
arious studies are not certain but may depend on sev-
ral practical and technical considerations. First, the
irus strains and cell lines differed: we used Oka strain
rown in human MeWo cells; the other studies involved
llen strain in simian BSC-1 cells. These differences
ight correlate with preferential usage of alternate poly-
denylation sites, just as HSV-1 polyadenylation speci-
icities have been found to differ according to temporal
tage of infection and other factors (McLauchlan et al.,
989). Second and perhaps more important, is that the 39
erminus defined by Gilligan (1994) and Cohrs et al.
1996) was based on sequencing of cDNAs prepared
rom latently infected human ganglia. The particular
DNA studied might not have represented the most
bundant species of transcripts; there may have been
thers that terminated further downstream. Moreover,
atent infection might be associated with the preferential
se of different processing signals than in lytic infection.
n this regard, we have reported alternate 59 start sites
or transcripts encoded by VZV gene 29 in lytic and latent
nfection (Meier et al., 1993).
Transient transfection experiments documented re-
ponsive promoter sequences upstream of the gene 21
ranscriptional start site and possibly extending into and
verlapping with the promoter for gene 20. As also seen
y Cohrs et al. (1998), the gene 21 promoter was strongly
esponsive to the major VZV immediate-early transacti-
ator, gene 62 alone. There was little or no response to
ther VZV regulatory genes 4, 10, or 61, but gene 4 did
emonstrate an additive effect on gene 21 activation by
2, as we have seen with other VZV genes (Kost et al.,
995). Gene 21 appeared to have no transregulatory
ctivity of its own.
The presence of overlapping promoters between two
pposing genes was shown previously for VZV genes 28
nd 29 (Meier et al. 1993, 1994). In both cases, there was
elective expression of only one of each pair of opposing
enes in latency: gene 29 but not 28; gene 21 but not 20.
RF 28 encodes the viral DNA polymerase, whereas
RF 29 encodes a major DNA-binding protein. The func-
ion of ORF 20 is not known, but its HSV-1 homolog is UL
8, which encodes a capsid assembly protein VP19C that cinds DNA and may anchor the genome in the capsid
Ward et al., 1996). ORF 21 shows 47% amino acid simi-
arity level to its HSV homolog, UL 37. UL 37 encodes a
ytoplasmic phosphoprotein that is transported to the
ucleus where it associates with ICP8 (Shelton et al.,
994). ICP8 binds DNA, is required for genome replica-
ion and may affect early and late gene expression.
VZV gene 21 protein has been detected in both the
ucleus and cytoplasm of infected cells, but it was not
ound in the virion tegument (Mahalingam et al., 1998).
oreover, gene 21 protein is one of several VZV products
proteins encoded by gene 4, 21, 29, 62, 63) detected by
mmunohistochemistry in latent infected human neurons
Lungu et al., 1998). The combined data suggests impor-
ant roles for gene 21. Targeted ORF21 deletion mutants
f VZV now are being constructed to determine whether
ene 21 is required for lytic and latent VZV infection.
MATERIALS AND METHODS
ells and virus
Human melanoma (MeWo) cells, originally provided by
harles Grose, were used for virus propagation. Vero
ells (American Type Culture Collection, Fairfax, VA)
ere used in transient transfection assays. The live at-
enuated Oka strain of VZV (Takahashi et al., 1975) was
ropagated by passage of infected cells onto uninfected
onolayers and incubated at 34°C. Eagle’s minimal es-
ential medium (Gibco BRL, Gaithersburg, MD) contain-
ng 10% fetal bovine serum was used for cell growth.
lasmids, probes, and primers
The DNA segment used for studies of ORF 21 was
erived from cosmid VZV NotI A (Cohen and Seidel,
993), which encompasses nt 1–45295 of the VZV Oka
train genome (Fig. 4). A 4.0-kb fragment (nt. 30211–
4225) released from the cosmid by AseI digestion,
hich spans ORF 21 (nt. 30759–33872), was cloned into
BR322 to form plasmid pBORF21. The same AseI frag-
ent was cut from pBORF21, blunt-ended, and sub-
loned into the HincII site of pGEM3Zf(1) to form
GORF21A, and a 2.0-kb ORF-21-specific BglII fragment
nt. 31044–33056) also cleaved from pBORF21 was in-
erted into the BamHI site of pGEM3Zf(1) to form
GORF21B.
In both of the pGEM3Zf(1)-based constructs, there are
wo potential directions for the inserts: clockwise and
ounterclockwise. Specific riboprobes 8 and 9, respec-
ively, were synthesized from the clockwise construct of
GORF21A and pGORF21B by in vitro transcriptional la-
eling with RNA polymerase SP6 and [a-32P]UTP (40
Ci/ml, 800 Ci/mmol, Amersham). Additional constructs
ere prepared by digesting the clockwise recombinant
GORF21A with BamHI and the counterclockwise re-
ombinant of pGORF21A with EcoRI. In each case, a
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311TRANSCRIPTION MAPPING OF VZV GENE 21.7-kb fragment containing the pGEM3Zf(1) sequences
nd a portion of gene 21 were released and recircular-
zed as new plasmids, pGORF21D and pGORF21C.
GORF21D contains VZV nt 32664–34225, from which
iboprobe 11 was prepared by using AvaI (nt. 33846)
igestion and SP6 RNA polymerase labeling. pGORF21C
ontains nt. 30211–31738 of VZV, from which DNA probe
0 was produced by BstEII (nt. 30847) digestion and 59
abeling with T4 DNA polynucleotide kinase and
g-32P]ATP (10 mCi/ml, 5000 Ci/mmol, Amersham, Arling-
on Heights, IL).
To construct the reporter construct p21CAT,
GORF21C was cleaved with HincII (30465) and NcoI
30757), and a 292-bp fragment spanning the ORF 21
romoter was inserted in place of SmaI–NcoI fragment
pstream of the CAT reporter gene in pCAT3Basic.
CMV21 was constructed by insertion of the blunt-ended
FIG. 4. Construction of plasmids used in the study. The uppermost
art of the figure shows the location of the gene 21 AseI fragment in the
ZV NotIA cosmid. In all plasmids listed, only the cleavage sites
elevant to their construction and probe preparation are shown. Only
he clockwise insert of the 4.0-kb AseI fragment is shown as
GORF21A. pGORF21C was constructed from reverse form of
GORF21A in which the 4.0-kb AseI fragment had inserted in the
ounterclockwise orientation (not shown).atII–BsrGI fragment (nt. 30648–33895) from pGORF21A Anto pCDNA3 (Invitrogene, Carlsbad, CA), with ORF 21
nder the control of the heterologous CMV promoter.
Oligonucleotide probes or primers (Table 1 and Fig 1)
ere labeled with [g-32P]ATP at the 59 end using T4 DNA
olynucleotide kinase. For all labeling procedures, unin-
orporated radiolabeled nucleotides were removed with
ucTrap Probe Purification Columns (Stratagene, La-
olla, CA).
NA analysis
Total cell RNA and polyadenylated [poly(A)1] RNA
ere prepared from VZV-infected MeWo cells achieving
0% cytopathic effects and from mock-infected cells us-
ng an RNAeasy Mini kit and an Oligotex Direct mRNA
ini kit (QIAGEN, Santa Clarita, CA), respectively. Twenty
icrograms of total RNA or 0.5 mg of poly(A)1 mRNA per
ane were subjected to electrophoresis on formaldehyde
enaturing agarose gels and transblotted onto Maximum
trength Nytran membranes (Schleicher and Schuell,
eene, NH). For RNA hybridizations with riboprobes, re-
ctions were carried out according to the membrane
anufacturer’s instructions. For oligonucleotide probes,
ybridizations were performed as modified from the lit-
rature (Zeff et al., 1986), i.e., at 10°C below the calcu-
ated melting temperature (Tm) for each probe in 6% SDS,
5 mM sodium phosphate (pH 7.0), 73 Denhart’s solu-
ion, 53 SSC, 8.5% dextran sulfate, and 0.1 mg/ml heat-
enatured salmon sperm DNA. Prehybridization was per-
ormed for 4 h in the same reaction mixture lacking
extran sulfate. After hybridization the filters were
ashed at 10°C below the Tm as described (Zeff et al.,
986).
S1 nuclease protection assays were performed with
n S1-Assay kit (Ambion, Austin, TX) using in vitro tran-
cribed [a-32P]UTP-labeled, single-stranded RNA probes,
s well as [g-32P]ATP-labeled, denatured DNA probes.
ingle-stranded RNA probes also were used in RNase
rotection assays. In these latter assays, hybridization of
he probe and sample RNA was carried out as in the
1-assay; however, the subsequent steps were per-
ormed as described (Sambrook et al., 1989).
Primer extension reactions were conducted with syn-
hetic oligonucleotide primers 3 and 4 predicted to hy-
ridize to RNAs encoded by gene 21 (Fig. 1) by the
ethod described (Sambrook et al., 1989) with modifica-
ion. Briefly, 10–50 ng of [g-32P]ATP-labeled primers were
ybridized to 30 mg of total RNA. Annealed RNA-primer
ybrids were allowed to form for 8 h at 42°C and sub-
equently were reverse-transcribed with 50 U of avian
everse transcriptase (Boehringer Mannheim, Indianap-
lis, IN). Products were separated on 6% sequencing
els (National Diagnostics, Atlanta, GA), and the sizes of
pecific bands were determined by sequencing
GORF21A DNA with the same primers (T7 Sequenase,
mersham, Cleveland, OH).
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312 XIA AND STRAUSransfection and transient expression assays
In addition to p21CAT and pCMV21 (described above),
he following previously described plasmids were used
n the assays: p4CAT, p29CAT, p61CAT, p62CAT, and
1TKCAT (Kost et al., 1995) in which CAT is driven by VZV
RF 4, ORF 29, ORF 61, ORF 62, and ORF 36 (TK) pro-
oters, respectively; pCMV4, pCMV10, pCMV61, and
CMV 62 express VZV ORF 4, ORF 10, ORF 61, and ORF
2, respectively, under the control of the human cytomeg-
lovirus (HCMV) major IE promoter (Moriuchi et al., 1994).
ero cells were plated at a density of 5 3 105 cells per
0-mm dish the day before transfection. DNAs used for
ransfection were prepared with QIAGEN Plasmid kits.
ransfection was conducted with calcium phosphate
recipitation according to the manufacturer’s instruc-
ions for the ProFection Mammalian Transfection System
Promega, Madison, WI). The amount of target promoter-
AT fusion constructs and effector plasmids used in
ach dish was 9 and 3 mg, respectively. Additional con-
rol DNA of pCMV or pcDNA3 (Invitrogen, Carlsbad, CA)
as added to achieve a total of 6 mg of DNA per trans-
ection when two effector plasmids were included in the
ame transfection. Glycerol shock was performed 16 h
fter transfection. For VZV superinfection, a monolayer of
ero cells was overlaid at 20–24 h with VZV-infected
eWo cells at a 1:4 ratio of infected to uninfected cells.
ells were harvested 60–72 h after transfection, assayed
or protein content by the Bradford method (Bio-Rad,
ercules, CA) and CAT expression was determined us-
ng the CAT Enzyme Assay System (Promega), in which
AT activity is quantitated by liquid scintillation counting
f n-butyryl chloramphenical (Seed and Sheen 1988) and
ormalized on the basis of total protein content. D-threo-
dichloroacetyl-1-14C]Chloramphenicol (25 mCi/ml, 55
Ci/mmol, Amersham) was used in the CAT assay.
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